For traders with a bullish short-term outlook on the U.S. cannabis sector, the AdvisorShares MSOS Daily Leveraged ETF (NYSEARCA: MSOX) provides a specialised instrument designed to amplify daily upside movements in U.S. cannabis equities. MSOX is a leveraged ETF that seeks to deliver enhanced daily exposure to the AdvisorShares Pure US Cannabis ETF (MSOS), which tracks leading U.S. multi-state operators and cannabis-related companies. As with all leveraged products, effective use of MSOX requires a clear understanding of its daily reset mechanism, short holding horizon, and the impact of compounding on returns beyond a single trading session.

Leveraged Exposure to a Policy- and Catalyst-Driven Sector
The U.S. cannabis industry is highly sensitive to regulatory developments, legislative progress, earnings updates, capital market access, and shifts in investor risk appetite. Price movements can be sharp and event-driven, particularly around developments such as federal rescheduling discussions, SAFE Banking Act progress, state-level legalization initiatives, or quarterly results from major multi-state operators. In this environment, leveraged ETFs like MSOX allow traders to express high-conviction, tactical bullish views with magnified sensitivity to daily price movements across the sector rather than to a single stock.
MSOX is structured to deliver, before fees and expenses, approximately two times (+2x) the daily performance of MSOS. In practical terms:
Because leverage is reset daily, MSOX’s performance over periods longer than one day may diverge materially from simply twice the cumulative return of MSOS, particularly in volatile or range-bound markets.
Who Should Consider MSOX?
The AdvisorShares MSOS Daily Leveraged ETF is intended for active, sophisticated traders who are comfortable managing leveraged exposures and monitoring positions closely. It is not designed for long-term investors or buy-and-hold strategies.
Common tactical use cases include:
Due to daily reset and compounding effects, MSOX requires active oversight, as multi-day holding periods can lead to outcomes that differ significantly from the expected +2x cumulative performance of MSOS.
Key Risks and Strategic Considerations
Before trading MSOX, investors should carefully evaluate the following:
Price Chart & Technical Summary


Conclusion
MSOX is a precision trading instrument designed to provide amplified daily long exposure to the U.S. cannabis sector via MSOS. For experienced traders who understand leveraged ETF mechanics and the policy-driven volatility inherent in cannabis equities, MSOX can be an effective tool for expressing short-term bullish views. However, its daily reset structure, sensitivity to compounding, and exposure to a highly volatile sector necessitate disciplined position sizing, active monitoring, and a clear understanding of leveraged product behavior across varying market conditions.
This report has been issued by Kalkine Limited (Company number 07903332), a private limited company, incorporated in England and Wales ("Kalkine”). Kalkine.co.uk and associated pages are published by Kalkine. Kalkine is authorised and regulated by the Financial Conduct Authority under reference number 579414.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice. The information in this report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain non personalized recommendations to invest in securities and other financial products.
Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall not be held liable for any investment or trading losses you may incur by using the opinions expressed in our reports, publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.
Please also read our Terms & Conditions for further information. Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Kalkine Media Limited, an affiliate of Kalkine, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this report.
Past performance is not a reliable indicator of future performance.